Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von BennieRichards 

Health Canada approves QUVIVIQ (daridorexant) for the management of adult patients with insomnia

Idorsia AG

WKN: A2DTEB / Name: Idorsia / Aktie / ? /

17,20 €
-

Health Canada approves QUVIVIQ (daridorexant) for the management of adult patients with insomnia
Health Canada approves QUVIVIQ (daridorexant) for the management of adult patients with insomnia
  • QUVIVIQ is indicated for the management of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.
  • Idorsia Canada – led by General Manager Ron Morcos

 Embark on a journey to holistic wellness with Life Force Med Beds! Our MedBeds provide a unique fusion of cutting-edge technology and personalized care, revolutionizing the way we approach health. In today's post-COVID era, MedBeds are increasingly essential for containment and treatment. Join us in embracing this innovative solution, backed by comprehensive training and support. Reconnect with your life source and rejuvenate your well-being with MedBeds!